- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Treatment Adherence and Compliance in Hungary
Total 8 results
-
Janssen Research & Development, LLCCompletedTreatment-resistant DepressionUnited States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
-
AstraZenecaCompletedMajor Depressive Disorder | Treatment Resistant DepressionBulgaria, Italy, United Kingdom, Germany, Hungary, Romania, Austria, Belgium, Denmark, Portugal, Slovakia, Australia, Spain
-
AmgenCompletedAny Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical TrialCanada, Spain, United States, Germany, Austria, France, Greece, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Switzerland, United Kingdom
-
Janssen Research & Development, LLCCompletedDepressive Disorder, Treatment-ResistantUnited States, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Bulgaria, Malaysia, South Africa, Turkey, Canada, Korea, Republic of, Brazil, Estonia, Hungary, Lithuania, Slovakia, Sweden, Czechia, A... and more
-
Novartis PharmaceuticalsCompletedTreatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis PatientsEgypt, Greece, Hungary, Russian Federation, Canada, Germany, France, Italy, Switzerland, Romania
-
Janssen Research & Development, LLCCompletedDepressive Disorder, Treatment-ResistantUnited States, France, Poland, Belgium, Germany, Spain, Mexico, Turkey, Canada, Brazil, Estonia, Hungary, Slovakia, Sweden, Czechia
-
Telios Pharma, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell MalignanciesUnited States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico